Comparative pharmacokinetics of enrofloxacin in healthy and Aeromonas hydrophila-infected crucian carp (Carassius auratus gibelio)

被引:24
作者
Fan, J. [1 ,2 ]
Shan, Q. [1 ]
Wang, J. [3 ]
Liu, S. [1 ]
Li, L. [1 ]
Zheng, G. [1 ]
机构
[1] Chinese Acad Fishery Sci, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Guangzhou 510380, Guangdong, Peoples R China
[2] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China
[3] Guangdong Lab Anim Monitoring Inst, Guangdong Prov Key Lab Lab Anim, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
SUSCEPTIBILITY; OXYTETRACYCLINE; CIPROFLOXACIN; FISH;
D O I
10.1111/jvp.12392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The comparative pharmacokinetics of enrofloxacin (ENR) and its metabolite ciprofloxacin (CIP) were investigated in healthy and Aeromonas hydrophila-infected crucian carp after a single oral (p.o.) administration at a dose of 10mg/kg at 25 degrees C. The plasma concentrations of ENR and of CIP were determined by HPLC. Pharmacokinetic parameters were calculated based on mean ENR concentrations by noncompartmental modeling. In healthy fish, the elimination half-life (T-1/2z), maximum plasma concentration (C-max), time to peak (T-max), and area under the concentration-time curve (AUC) values were 64.66h, 3.55g/mL, 0.5h, and 163.04g<bold>h</bold>/mL, respectively. In infected carp, by contrast, the corresponding values were 73.70h, 2.66g/mL, 0.75h, and 137.43g<bold>h</bold>/mL, and the absorption and elimination of ENR were slower following oral administration. Very low levels of CIP were detected, which indicates a low extent of deethylation of ENR in crucian carp.
引用
收藏
页码:580 / 582
页数:3
相关论文
共 18 条
[1]   Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves [J].
Balaje, R. M. ;
Sidhu, P. K. ;
Kaur, G. ;
Rampal, S. .
RESEARCH IN VETERINARY SCIENCE, 2013, 95 (03) :1114-1124
[2]   The disposition of enrofloxacin in seabream (Sparus aurata L.) after single intravenous injection or from medicated feed administration [J].
della Rocca, G ;
Di Salvo, A ;
Malvisi, J ;
Sello, M .
AQUACULTURE, 2004, 232 (1-4) :53-62
[3]   Pharmacokinetics of enrofloxacin in snakehead fish, Channa argus [J].
Fang, X. ;
Zhou, J. ;
Liu, X. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (02) :209-212
[4]   Pharmacokinetics of enrofloxacin in allogynogenetic silver crucian carp, Carassius auratus gibelio [J].
Fang, X. ;
Liu, X. ;
Liu, W. ;
Lu, C. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 (04) :397-401
[5]   Pharmacokinetics of enrofloxacin in the seabass (Dicentrarchus labrax) [J].
Intorre, L ;
Cecchini, S ;
Bertini, S ;
Varriale, AMC ;
Soldani, G ;
Mengozzi, G .
AQUACULTURE, 2000, 182 (1-2) :49-59
[6]   Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus) [J].
Kim, M. -S. ;
Lim, J. -H. ;
Park, B. -K. ;
Hwang, Y. -H. ;
Yun, H. -I. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (05) :397-402
[7]   Pharmacokinetic disposition of enrofloxacin in brown trout (Salmo trutta fario) after oral and intravenous administrations [J].
Koc, F. ;
Uney, K. ;
Atamanalp, M. ;
Tumer, I. ;
Kaban, G. .
AQUACULTURE, 2009, 295 (1-2) :142-144
[8]   Pharmacokinetics and tissue behavior of enrofloxacin and its metabolite ciprofloxacin in turbot Scophthalmus maximus at two water temperatures [J].
Liang Junping ;
Li Jian ;
Zhao Fazhen ;
Liu Ping ;
Chang Zhiqiang .
CHINESE JOURNAL OF OCEANOLOGY AND LIMNOLOGY, 2012, 30 (04) :644-653
[9]   Antimicrobial susceptibility of Aeromonas spp., Vibrio spp. and Plesiomonas shigelloides isolated in the Philippines and Thailand [J].
Maluping, RP ;
Lavilla-Pitogo, CR ;
DePaola, A ;
Janda, JM ;
Krovacek, K ;
Greko, C .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (04) :348-350
[10]   Pharmacology of the fluoroquinolones: A perspective for the use in domestic animals [J].
Martinez, Marilyn ;
McDermott, Patrick ;
Walker, Robert .
VETERINARY JOURNAL, 2006, 172 (01) :10-28